Acurx Pharmaceuticals share price logo

Acurx Pharmaceuticals

NASDAQ: ACXP

$1.39

as on

Acurx Pharmaceuticals Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's High

    $1.39
    $1.42

    2.16%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.31
    $8.34
    downward going graph

    5.76%

    Downside

    500.00%

    Upside

    downward going graph

Acurx Pharmaceuticals share price movements today

Previous Close
$1.39
Open
$1.39
Volume
299.5K
Market Cap
$5.9M
Day's Low - High
$1.39 - $1.42
52 Week Low - High
$1.31 - $8.34

Acurx Pharmaceuticals Historical Returns

1 Month Return
-3.47 %
3 Month Return
-9.74 %
1 Year Return
-66.1 %
3 Year Return
-95.94 %
5 Year Return
-98.48 %

Acurx Pharmaceuticals Stock Fundamentals & Key Indicators

Check Acurx Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.9M

EPS (TTM)

-3.55

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.39

Industry PE ratio

-2.37

PEG Ratio

-0.0028873177612293356

EBITDA

-7.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-124.74%

Acurx Pharmaceuticals Stock Valuation

Track how Acurx Pharmaceuticals P/E has moved over time to understand its valuation trends.

Acurx Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-3.56x)

December 31, 2022

Industry (-2.37x)

December 31, 2025

Today (-0.47x)

December 31, 2025

Highest (-0.47x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.47x

Acurx Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Acurx Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$5.9M-98.48%-0.390.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Acurx Pharmaceuticals Stock including INR - Dollar returns

The Acurx Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Acurx Pharmaceuticals investment value today

Current value as on today

₹36,896

Returns

-₹63,104

(-63.1%)

Returns from Acurx Pharmaceuticals Stock

-₹66,098 (-66.1%)

Dollar Impact

₹2,994 (+2.99%)

Analyst Recommendation on Acurx Pharmaceuticals Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Acurx Pharmaceuticals. Average target price of $17

Acurx Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Acurx Pharmaceuticals.

What analysts predicted

91.82%UPSIDE

Target Price

$17

Current Price

$1.39

Analyzed by

2 Analysts

Target

$17.00

Acurx Pharmaceuticals target price $17, a slight upside of 91.82% compared to current price of $1.39. According to 2 analysts rating.

Indian Investors' Interest in Acurx Pharmaceuticals Stock

Search interest for Acurx Pharmaceuticals Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-32% versus previous 30 day period

Acurx Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-4
-4
-2
-2
-2
-2
-2
-1
-1
-2
EBITDA
-4
-4
-
-
-
-2
-1
-1
-1
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
2
2
2
-
-
-
-
-
Income Before Tax
-4
-4
-2
-2
-2
-2
-1
-1
-1
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-4
-4
-2
-2
-2
-2
-1
-1
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Acurx Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
Operating Income
-5
-4
-12
-12
-14
-14
-8
EBITDA
-
-
-12
-12
-14
-
-7
Interest Expense
-
-
-
-
-
-
-
Depreciation
5
4
-
-
-
14
-
Income Before Tax
-5
-4
-12
-12
-14
-14
-7
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-5
-4
-12
-12
-14
-14
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Acurx Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-4
-2
-2
-2
-2
-1
-1
-1
-2
Operating Cash Flow
-3
-2
-2
-2
-2
-1
-1
-1
-1
-1
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
4
0
1
0
2
3
1
2
3
3
Change in Cash
1
-2
0
-2
0
1
0
1
1
1

Acurx Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-4
-12
-12
-14
-14
-7
Operating Cash Flow
-3
-3
-5
-7
-9
-10
-6
Investing Cash Flow
-
-
-
-
-
-
-
Financing Cash Flow
4
4
14
3
8
6
10
Change in Cash
0
0
9
-3
-1
-3
3

Mutual Funds that own Acurx Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Acurx Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
0.559394%
31099
Fidelity Concord Street Trust
0.245242%
13634
Victory Portfolios III
0.018437%
1025

Global Institutional Holdings in Acurx Pharmaceuticals

Funds
Holdings
Vanguard
0.56%

Insights on Acurx Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 44.3% return, outperforming this stock by 140.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 576.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, ACXP stock has moved down by -79.0%

About Acurx Pharmaceuticals

Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate is ibezapolstat, an antibiotic that utilizes a novel mechanism of action by targeting the polymerase IIIC enzyme. Ibezapolstat has successfully completed Phase II clinical trials for addressing Clostridium difficile infections. Additionally, Acurx is progressing with ACX-375C, an investigational therapeutic suitable for both oral and injectable administration. This compound is being developed to combat various gram-positive bacteria, including resistant strains such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and penicillin-resistant Streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was established in 2017 and is headquartered in Staten Island, New York.
OrganisationAcurx Pharmaceuticals
Headquarters259 Liberty Avenue, Staten Island, NY, 10305, US
IndustryBiotechnology
CEODavid Luci
E-voting on sharesClick here to vote

Key Management of Acurx Pharmaceuticals

Name

Title

Mr. Robert J. DeLuccia

Co-Founder & Executive Chairman

Mr. David P. Luci C.P.A., Esq., J.D.

Co-Founder, President, CEO, Corporate Secretary & Director

Mr. Robert G. Shawah C.P.A.

Co-Founder & CFO

Dr. Michael H. Silverman B.Sc., F.A.C.P., FACR, M.B.A., M.D.

Medical Director

FAQs

What is Acurx Pharmaceuticals share price today?

Acurx Pharmaceuticals share price today is $1.39 as on at the close of the market. Acurx Pharmaceuticals share today touched a day high of $1.42 and a low of $1.39.

What is the 52 week high and 52 week low for Acurx Pharmaceuticals share?

Acurx Pharmaceuticals share touched a 52 week high of $8.34 on and a 52 week low of $1.31 on . Acurx Pharmaceuticals stock price today i.e. is closed at $1.39,which is 83.33% down from its 52 week high and 6.11% up from its 52 week low.

What is Acurx Pharmaceuticals's market capitalisation today?

Acurx Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Acurx Pharmaceuticals Stock (ACXP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Acurx Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acurx Pharmaceuticals Shares that will get you 1.0791 shares as per Acurx Pharmaceuticals share price of $1.39 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Acurx Pharmaceuticals Stock (ACXP) from India?

Indian investors can start investing in Acurx Pharmaceuticals (ACXP) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Acurx Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Acurx Pharmaceuticals share’s latest price of $1.39 as on September 19, 2026 at 8:46 am IST, you will get 7.1942 shares of Acurx Pharmaceuticals. Learn more about fractional shares .

What are the returns that Acurx Pharmaceuticals has given to Indian investors in the last 5 years?

Acurx Pharmaceuticals stock has given -98.48% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?